Sign In to Follow Application
View All Documents & Correspondence

An Improved Process For Preparing 1 (Pentanoylamino)cyclopentanecarboxylic Acid

Abstract: The present invention relates to an improved process for preparing 1-(pentanoylamino)cyclopentanecarboxylic acid formula (I) which is useful intermediate for the preparation of Irbesartan

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
06 January 2009
Publication Number
36/2010
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

ALEMBIC LIMITED
ALEMBIC CAMPUS, ALEMBIC ROAD, VADODARA 390003, GUJARAT, INDIA.

Inventors

1. PONNAIAH  RAVI
ALEMBIC LIMITED, ALEMBIC ROAD, VADODARA 390003, GUJARAT, INDIA.
2. DESAI  SANJAY
ALEMBIC LIMITED, ALEMBIC ROAD, VADODARA 390003, GUJARAT, INDIA.
3. RATHOD  DHIRAJ
ALEMBIC LIMITED, ALEMBIC ROAD, VADODARA 390003, GUJARAT, INDIA.
4. PARIKH  CHIRAG
ALEMBIC LIMITED, ALEMBIC ROAD, VADODARA 390003, GUJARAT, INDIA.
5. MOKAL  RAMESH
ALEMBIC LIMITED, ALEMBIC ROAD, VADODARA 390003, GUJARAT, INDIA.

Specification

FORM 2
THE PATENTS ACT, 1970
(39 OF 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See section 10; rule 13)
1. Title of the invention -AN IMPROVED PROCESS FOR PREPARING I-
(PENTANOYLAM1NO) CYCLOPENTANECARBOXYL1C ACID

2. Applicant(s)
(a) NAME :
(b) NATIONALITY:
(c) ADDRESS:

ALEMBIC LIMITED
An Indian Company.
Alembic Campus, Alembic Road. Vadodara-390, 003, Gujarat. India


3. PREAMBLE TO THE DESCRIPTION

The following specification particularly describes the invention and the manner in which it is to be performed:


An improved process for preparing l-(pentanoylamino)cyclopentanecarboxviic acid
Field of the invention:
The present invention relates to an improved process for preparing 1-(pemanoylamino)cyclopentanecarboxylie acid formula (I) which is useful intermediate for the preparation of Irbesartan


Background of the invention:
The chemical name of Irbesartan is 2-Butyl-3-[|2XlH-teirazol-5-yl)lT J'^iphcnylj^-yllmethylJ-l.S-diazaspirojA^Jnon-l-en^-one and formula is t^slI^NoO and molecular weight is 428.53. The current pharmaceutical product containing this drug is being sold by Sanofi Synthelabo using the tradename AVAPRO. in the form of tablets.
Irbesartan is useful in the treatment of diabetic nefropathy. heart failure tberapx and hypertension. Irbesartan is angiotensin 11 type I (Alli)-receptor antagonist. Angiotensin 11 is the principal pressor agent of the rennin-angiotension system and also stimulates aldosterone synthesis and secretion by adrenal cortex, cardiac contraction, renal resorption of sodium, activity of the sympathetic nervous system and smooth muscle ceil growth. Irbesartan blocks the vasoconstrictor and aldosterone- secreting effects of angiotensin II by selectively binding to the AT] angiotensin II receptor.
1

l-(pentanoylamino)cyclopentanecarboxylic acid (!) is useful intermediate in the preparation of irbesartan. The present invention provides an improved process for the pareparation of this intermediate.
US5270317 disclose process for preparation of 1-Aminocyclopentanenitrile by reacting cyclopentanone with sodium cyanide in the presence of ammonium chloride in water and 20% aqueous ammonia.
Canadian Patent No. 2050769 provides a process for (pentanoylamino)cyclopentanecarboxylic acid (1) and intermediate. The synthetic scheme is as given below.

This process comprises the steps of protecting carboxylic group present on cyclopentane ring which is deprotected in consecutive step by vigourous hydrogenation condition in autoclave which is operationally difficult at a large scale.
WO2005113518 discloses the process of preparation of 1 -(pentanoylamino)cyclopentanecarboxylic acid (I) and subsequently frb^saaan b\ condensing 1-amino-cyclopentanecarboxylic acid with valeroyl chloride in presence- ot
?

inorganic or organic base to give l-(pentanoylamino)cyclopentanecarboxyIic acid (1). This compound is further condensed with 2-(4-aminomelhyl phenyl) benzonitriie using dicyclocarbodiimide (DCC) and 1-hydroxy benzotriazole as catalyst to give an open chain intermediate which is then cyclized in the presence of an acid to give cyano derivative which in turn is converted to Irbesartan by treating it with tributyl tin chloride and sodium azide.

Farmuco-Ed. Sc.-vol XXI. FASC.9 discloses a process for preparation of 1-(pentanoylamino)cyclopentanecarboxylic acid (J) according the below given scheme


Pyridine. COOH 0.5OC
COOH
n-C^COCl

'4"9

In this process 1-amino cyclopentanecarboxylic acid is reacted with valeroyl chloride in the presence of pyridine to give l-(pcnlanoylaminojcyelopenianecarboxylic acid (Ij. However, pyridine is hazardous reagent and it is not advisable to use at industrial scale because of environment concern. The reaction requires low temperature such as 0 to 5 'C Further, in this process dimer impurity forms which is difficult to remove after repealed crystallization.

Synthetic Communication, 37: 2897-2905, 200/ discloses a process for preparation of 1-(pentanoylamino)cyclopentanecarboxylic acid (1) according the below given scheme.
t
In second step of this process, cyano group is first converted to amide to give amide intermediate fa)
which is then further converted acid of formula (J). In the conversion of amide intermediate (a) to l-(pentanoylamino)cyclopentanecarboxylic acid (I), there always remains 4 to 5% amide intermediate (a) unreacted. It leads to presence of unwanted 3-4% amide impurity in the final compound (Ij which is difficult to remove after repeated crystallization. The prolonged duration of the reaction lime and the excess amount of hydrochloric acid does not reduce the amount of amide intermediate (a) in the final compound (1).
US Patent No. 7038060 also discloses the process of preparation of lrbesartan from 4-bromomethyl biphenyl 2;-(lH-tetrazol (2-triphenylmethyi) 5-yl) and Kihyl ester of 1-Valeramido cyclopentanecarboxylic acid in toluene in presence of base and P'l'C. and then hydrolyzing the protecting group. However this requires chromatographic purification.
All the above patents/applications are incorporated herein as reference.
4

It is therefore, a need to develop a process which not only overcomes the disadvantages of the prior art but also economical, operationally simple and industrially applicable.
Present inventors have directed their research work towards developing a process for the preparation of l-(pcnlanoylamino)cyc]opentanecarboxylic acid (I) which is devoid of the above disadvantages. The present inventors found that when N-(l-cyanocyclopentyl)pentanamide (V) is hydrolyzed with hydrochloric acid alone, the unreaeted amide intermediate (a) in remains 4 to 5% in final compound (1). Whereas when it is hydrolyzed in the presence of combination of hydrochloric acid and acetic acid, the amount of unreaeted amide intermediate (a) reduces to less than 0.5% in the final compound l-(pentanoylamino)cyclopentanecarboxylic acid (1).
Summary of the invention:
It is therefore an object of the present invention is to provide an improved process for the preparation of l-(pentanoylamino)cyclopentanecarboxylic acid (I).
Another object of the present invention is to provide an improved process for the preparation of Irbesarian using l-(pentanoylamino)cyclopentanecarboxylic acid (1).
Another object of the present invention is to provide a process for preparation of i-(pentanoylamino)cyclopentanecarboxylic acid (1) which is simple and easy to handle at an industrial scale.
Another object of the present invention is to provide a process for preparation o\ !-(pentanoyiamino)cyciopentaneearboxylie acid (1) in which amide impurity (a) is ievs tlian 0.5%.
Accordingly, present invention provides an improved process of preparation of 1-(pentanoylamino)cyclopentanecarboxylic acid (1)
D

comprising a step of reacting N-(l-cyanocycJopemy!)pcnlanamidc (V)

wilh hydrochloric acid and acetic acid to give (penlanoyiamino)cyclopentanecarboxyHc acid (I)
The present invention provides an improved process of preparation til (pcntanovlamino)cyclopentanecarboxylic acid (1)

having an amide impurity fa) less than 0.5%



comprising a step of reacting N-(l-cyanocyclopeniyl)pentanarnide (V) o
NH

with hydrochloric acid and acetic acid to give (pentanoylamino)cyclopenianecarboxylic acid (I)
The present invention provides an improved process of preparation of (pentanoylamino)cyclopentanecarboxylic acid (I)
6


(I)
comprising steps of:
(i) reacting cyclopentanone (III)

with sodium cyanide in the presence of ammonium chloride and soKent. dichloromethane to obtain 1-aminocyclopentane carbonitrile (IV)

(ji) reacting ]-aminocyclopentanc carbonitrile (JV) obtained in step (i) with valeroyl chloride in the presence of triethylamine and dichloromethane to obtain N-(I-cyanocyclopentyl)pentanamide (V)

(iii) reacting N-(l-cyanocyclopentyl)pentanamide (V) obtanined in step (ii) with
hydrochloric acid and acetic acid to give 1-
(pentanoylamino)cyclopentanecarboxylic acid (1)
The present invention provides an improved process of preparation of Irbesartan
7

comprising steps of: reacting cyclopentanone (III)

with sodium cyanide in the presence of ammonium chloride and solvent dichloromethane to obtain 1-aminocyclopentane carbonitrile (IV)

reacting 1-aminocyclopentane carbonitrile (IV) obtained in step (i) uith va'civw chloride in the presence of triethylamine and dichloromethane to obtain K-j-cyanocyclopentyl)pentanamide (V)

reacting N-(l-cyanocyclopentyl)pentanamide (V) obtanined in step (ii
hydrochloric acid and acetic acid to give
(pentanoylamino)cyc]opentanecarbo,\ylic acid (I)

Will


8

Detailed description of the invention:
The present invention provides an improved process * of preparation of 1 -(pentanoylamino)cyelopcntanecarboxylic acid (I)

comprising steps of:
(i) reacting cyclopentanone (III)
with sodium cyanide in the presence of ammonium chloride and solvent dichloromethane to obtain l-aminocyclopentane carbonitrilc (IV)

(ii) reacting l-aminocyclopentane carbonitriie (IV) obtained in step (i) with valeroyl chloride in the presence of triethylamine and dichloromethane to obtain N-(l-cyanocyclopentyOpentanamide (V)

(iii) reacting N-(l-cyanocyclopenlyl)pentanamide (V) obtanined in step (ii) with
hydrochloric acid and acetic acid to give 1-
(pentanoylamino)cyclopentanccarboxylic acid (I)
9


] sodium cyanide is dissolved in water. An aq. ammonium chloride solution and 20% aq. ammonia solution is added to the reaction mixture. Cyclopentanone in methanol is added to the reaction mixture and stirred for about one and a half hour. The mixture is heated at about 60°C for about 45 min. The reaction mixture is cooled to 25°C and extruded several times with dichloromethane. The combined dichloromethane is dried over sodium sulfate and concentrated under vacuum to give 1-aminocyclopentane carbonitrile (IV) in the form of oil.
l-aminocyclopenatne carbonitrile in dichloromethane is cooled at lOaC and triehlyi amine is added to it. Valeroyl chloride is added to the reaction mixture at about 5"(. to about 10°C. The reaction mixer is stirred at the same temperature for about 2 hrs and liven further stirred at room temperature for about I hrs. DM Water is charged to the reaction mixture and organic layer is separated. The organic layer is evaporated to gel N-fl-cyanocyclopentyl)pentanamide (V) as oil. This oil is used for hydrolysis step
The oil obtained above is mixed with water, cone, hydrochloric acid and acetic acid and heated at about 60°C for about 24 hrs. The reaction mixture is cooled to room temperature and maintain for I hour. The solid product is filtered and washed with water. The product is suck dried and dried in oven under reduced pressure to give l-(penlanoylamino) cyclopentanecarboxylic acid (J)
l-(pentanoylamino) cyclopentanecarboxylic acid (1) is converted to Irbesarlan by the methods known in the art. l-(penlanoylamino) cyclopentanecarboxylic acid (1) is reacted
10

wilh 2-(4-aminomelhyl phenyl) benxonitrile in the presence of DCC to give condensed intermediate. The corresponding intermediate is cyclized in presence of acid and then the formed cyano irbesartan is converted lo Irbesartan by reacting it with sodium a/ide to form tetrazole moiety.
The following examples illustrate the invention further. It should be underwood. however, that the invention is not confined to the specific limitations set forth in the individual examples but rather to the scope of the appended claims.
Example-1
Preparation of 1-aminocyclopentane carbonitrile (IV)
1.97 g of sodium cyanide are dissolved in 3.9 ml of water in a round-bottomed flask and a solution containing 2.33 g of ammonium chloride in 5.9 ml of water and 3.5 ml of 20% aqueous ammonia is added; finally, 3 g of cyclopentanone in 3.8 ml of methanol are added to the flask. After stirring for 1 and a half hours, the mixture is heated at 60°C for 45 minutes, heating is then stopped, stirring is continued for 45 minutes and the mixture is then cooled to 25°C It is extracted several times wilh dichloromelhane. The extracts are dried over sodium sulfate, filtered and concentrated under vacuum (o give ?-aminocyelopentane carbonitrile (IV) in the form of oil (4 g).
Example-2
Preparation of N-(l-cyanocycIopentyI)pentananiide (V)
1-aminocyclopenatne carbonitrile (30.0 g) in dichloromelhane (180 ml) was cooled to 10°C. Triehtyl amine (24 ml) was added to the reaction mixture and stirred. Valeroyl chloride (32.8 ml) was added at 5°C to 10°C and stirred at the same temperature for 2 hrs. The reaction mixture was further stirred at room temperature for 1 hour. DM Water was charged to the reaction mixture and organic layer was separated. The organic layer was evaporated lo dryness to get N-(l-cyanocyclopenlyl) pentanamide (V) as an oil (30.0g)
11

Example-3
Preparation of l-(pentanoylamino) cyclopentane carboxylie acid
N-(]-cyanocyclopentyl) pentanamide (V) (30.0 a) obtained iji example-! is mixed vviih reacts with cone, hydrochloric acid (30.0 ml), water (60.0 ml), acetic acid (10.0 ml) and heated al 60°C for about 24 hrs. The reaction mixture is cooled to room temperature and maintain for 1 hour. The solid product is filtered and washed with water. The product is suck dried and dried in oven under reduced pressure to give J-(pentanoylamino) cyelopentanecarboxyiic acid (1) (24.0 g) Purity by HPLC: 99%
12

What is claimed is:
1. A process of preparation of l-(pcntanoylamino)cyclopentanecarboxylic acid (I)



2.

comprising a step of reacting N-(l-cyanocyc]opentyl)pentananiidc (V) o
NH'
with hydrochloric acid" and acetic acid to give (pentanoylamino)cycloperuanecarboxyiic acid (I)
A process of preparation of l-(pentanoylamino)cyclopentanecarboxylie acid (1) o 'NH'

having an amide impurity (a) less than 0.5%

H2NOC
(a)


comprising a step of reacting N-f l-cyanocyciopentyi)pentanamide (V o 'NH'

with hydrochloric acid and acetic acid to give (pentanoylamino)cyclopenianccarboxylic acid (f)
3. A process of preparation of l~(pentanoylamino)cyclopenlanecarboxylic acid (1)
13

comprising steps of: reacting cyclopentanone (III)


(III)

with sodium cyanide in the presence of ammonium chloride and solvent diehloromethane to obtain 1-aminoeyclopentane carbonitrile (IV)
NC NH2 (IV)
reacting 1-aminocyclopentane carbonitrile (IV) obtained in step (i) with \aieroyl chloride in the presence of triethylamine and diehloromethane to obtain N-(l-cyanocyclopentyl)pentanamide (V)


o
NH
reacting N-(I-cyanocyclopentyl)pentanamide (V) obtanined in step (ii; with
hydrochloric acid and acetic acid to give 1-
(penianoylamino)cyelopentanecarboxylic acid (I)
A process of preparation of lrbesarian
14

comprising steps of: reacting cyclopentanone (]]I)

o (III)
with sodium cyanide in the presence of ammonium chloride and solvent dichloromethane to obtain 1-aminocyclopentane carbonitrile (IV)

reacting 1-aminocyclopentane carbonitrile (IV) obtained in step (i) with \:J'.:RAI chloride in the presence of triethyiamine and dichloromethane to obiuin sV\"-cyanocyciopentyI)pentanamide (V)

NH
reacting N-(l-cyanocyclopentyl)pentanamide (V) obtanincd in step (ii) with
hydrochloric acid and acetic acid to give J-
(pentanoylamino)cyelopentanccarboxylic acid fl)

'NH*
15

5. A process of preparation of Irbesarlan


H,C

comprising a slep of reading N-(l-cyanocycJopenlyl)pcntanamide (V)

with hydrochloric acid and acetic (pentanoylamino)cyclopentanecarboxvlic acid (I)

acid to eive


Dated this 30th day of December 2008



Dr. Alpesh Pathi Applicant's Agent

16

Documents

Application Documents

# Name Date
1 29-mum-2009-abstract.doc 2018-08-10
1 Power of Authority.pdf 2018-08-10
5 29-mum-2009-form 5.pdf 2018-08-10
6 29-mum-2009-form 3.pdf 2018-08-10
7 29-MUM-2009-FORM 3(2-2-2010).pdf 2018-08-10
8 29-mum-2009-form 2.pdf 2018-08-10
10 29-mum-2009-form 2(title page).pdf 2018-08-10
11 29-mum-2009-form 1.pdf 2018-08-10
12 29-mum-2009-description(complete).pdf 2018-08-10
14 29-mum-2009-correspondence.pdf 2018-08-10
15 29-MUM-2009-CORRESPONDENCE(2-2-2010).pdf 2018-08-10
16 29-mum-2009-claims.pdf 2018-08-10
18 29-mum-2009-abstract.pdf 2018-08-10
19 Power of Authority.pdf 2018-08-10